Literature DB >> 2968936

Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity.

S P LeDoux1, C R Hall, P M Forbes, N J Patton, G L Wilson.   

Abstract

A common mechanism has been proposed for the beta-cell toxins alloxan (ALX) and streptozocin (STZ) involving the formation of single-strand breaks in DNA that lead to the overactivation of the enzyme poly(ADP-ribose) synthetase and the critical depletion of its substrate NAD. If the toxins act via this common mechanism, the poly(ADP-ribose) synthetase inhibitors nicotinamide and thymidine would be expected to affect the formation of DNA single-strand breaks in a similar fashion. To test the effects of these inhibitors, the formation of single-strand breaks in the DNA of insulin-secreting RINr cells was monitored by assessing changes in the supercoiling of nucleoids after exposure to STZ, ALX, or methylnitrosourea (MNU). With the inclusion of nicotinamide or thymidine and STZ or MNU, more single-strand breaks in RINr cell DNA were detected. These results would be expected if nicotinamide and thymidine acted through inhibition of poly(ADP-ribose) synthetase. However, when the inhibitors were used in combination with ALX, fewer single-strand breaks were present. This suggests a reduction in ALX-induced hydroxyl radicals available to interact with DNA. Because nicotinamide has been demonstrated to be a hydroxyl-radical scavenger, the ability of thymidine to scavenge hydroxyl radicals was investigated. Thymidine, like nicotinamide, was found to be a potent scavenger of hydroxyl radicals. Thus, the mechanisms by which nicotinamide and thymidine protect against the toxic effects of STZ or ALX appear different. These findings suggest that the actions of beta-cell toxins are more complex than simply the overactivation of a single enzyme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968936     DOI: 10.2337/diab.37.8.1015

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

Review 1.  Does the mitochondrial DNA play a role in the pathogenesis of diabetes?

Authors:  K D Gerbitz
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

2.  DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction.

Authors:  A Rabinovitch; W L Suarez-Pinzon; Y Shi; A R Morgan; R C Bleackley
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

3.  N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets.

Authors:  F J Bedoya; F Solano; M Lucas
Journal:  Experientia       Date:  1996-04-15

Review 4.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

Review 5.  The development of mitochondrial medicine.

Authors:  R Luft
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats.

Authors:  T Annadurai; A R Muralidharan; T Joseph; M J Hsu; P A Thomas; P Geraldine
Journal:  J Physiol Biochem       Date:  2012-01-11       Impact factor: 4.158

7.  Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells.

Authors:  T Otonkoski; G M Beattie; M I Mally; C Ricordi; A Hayek
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Nicotinamide increases systemic vascular resistance in ovine endotoxemia.

Authors:  Marion Scharte; Jerzy-Roch Nofer; Hugo Van Aken; Rene Waurick; Jörg Meyer; Hans-Georg Bone
Journal:  Intensive Care Med       Date:  2003-05-01       Impact factor: 17.440

9.  Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil.

Authors:  G M Pieper; G J Gross
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

10.  Macrophage cytotoxicity towards isolated rat islet cells: neither lysis nor its protection by nicotinamide are beta-cell specific.

Authors:  K D Kröncke; J Funda; B Berschick; H Kolb; V Kolb-Bachofen
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.